Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PLX PHARMA INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

05/14/2021 | 07:02am EDT

Item 2.02 Results of Operations and Financial Condition.

On May 14, 2021, PLx Pharma Inc. (the "Company") issued a press release announcing its financial results for its first quarter ended March 31, 2021. The Company's press release is attached hereto as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report.

The information furnished by the Company pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits
    Exhibit No. Description

99.1 Press Release, dated May 14, 2021.

© Edgar Online, source Glimpses

All news about PLX PHARMA INC.
07/27PLX PHARMA : to Make Vazalore Available in Over 2,400 Rite Aid Stores in August
MT
07/26PLX PHARMA : VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
AQ
07/26PLx Pharma Inc.’s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
CI
07/22PLX PHARMA : to Discuss 2021 Second Quarter Financial Results on August 6, 2021 ..
AQ
07/20AFTER HOURS WATCH LIST SCORECARD : Plxp, ppg, ardx
MT
07/20PLx Shares Rise as Walgreens Set to Carry Vazalore in Stores
DJ
07/20SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Tuesday
MT
07/20PLX PHARMA : JMP Securities Adjusts PLx Pharma's Price Target to $21 From $12, K..
MT
07/19MT NEWSWIRES AFTER HOURS WATCH LIST : Plxp, ppg, ardx
MT
07/19PLX PHARMA : Shares Up 15% on VAZALORE's Walgreens Launch
MT
More news
Financials (USD)
Sales 2021 5,73 M - -
Net income 2021 -27,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -14,2x
Yield 2021 -
Capitalization 430 M 430 M -
Capi. / Sales 2021 75,1x
Capi. / Sales 2022 16,2x
Nbr of Employees 10
Free-Float 81,8%
Chart PLX PHARMA INC.
Duration : Period :
PLx Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PLX PHARMA INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 18,73 $
Average target price 21,50 $
Spread / Average Target 14,8%
EPS Revisions
Managers and Directors
Natasha Giordano President, Chief Executive Officer & Director
Rita M. O'Connor CFO, Head-Manufacturing & Supply Chain
Michael J. Valentino Executive Chairman
Gary S. Balkema Independent Director
Kirk K. Calhoun Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PLX PHARMA INC.239.31%430
GILEAD SCIENCES, INC.19.86%85 648
BIONTECH SE302.78%79 303
WUXI APPTEC CO., LTD.33.61%68 112
REGENERON PHARMACEUTICALS20.70%59 505
VERTEX PHARMACEUTICALS-14.71%52 232